| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/25/2006 | US7081562 obtained by backcrossing a mouse whose function of immunoglobulin Fc gamma receptor IIB gene is deficient on its chromosome and a wild-type collagen-induced arthritis-susceptible DBA/1J mouse six times or more |
| 07/25/2006 | US7081561 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof |
| 07/25/2006 | US7081523 And stimulate erythropoiesis; teatment of anemia |
| 07/25/2006 | US7081520 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 07/25/2006 | US7081513 Peptides having Chemotaxis Inhibitory Protein from Staphylococcus aureus (CHIPS) activity for diagnosis, prophylaxis and treatment of inflammation and HIV |
| 07/25/2006 | US7081363 Plant growth regulators; inserting genes; genetic engineering |
| 07/25/2006 | US7081362 For cultivating liquid materials such as cells or blood plasma in a culture medium |
| 07/25/2006 | US7081360 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 07/25/2006 | US7081341 A plasmid containing an rRNA gene having a mutant Anti-Shine-Dalgarno sequence, at least one mutation in such rRNA gene, and a genetically engineered gene which encodes a selectable marker having a mutant Shine-Dalgarno sequence |
| 07/25/2006 | US7081337 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases |
| 07/25/2006 | US7081241 Extracellular rage binding protein (EN-RAGE) and uses thereof |
| 07/25/2006 | US7081240 Protein mixtures for wound healing |
| 07/25/2006 | CA2333966C Media for culturing animal cells and process for producing protein by using the same |
| 07/25/2006 | CA2206423C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 07/25/2006 | CA2188264C Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof |
| 07/25/2006 | CA2156935C Methods of detecting collagen degradation in vivo |
| 07/20/2006 | WO2006076627A2 Methods and compositions related to modulating the extracellular stem cell environment |
| 07/20/2006 | WO2006076567A2 Microfluidic rare cell detection device |
| 07/20/2006 | WO2006076423A2 Genes and uses for plant improvement |
| 07/20/2006 | WO2006076374A1 Bone marrow stromal cells for immunoprotection of transplanted neural stem cells |
| 07/20/2006 | WO2006076099A2 Nucleotide sequences and corresponding polypeptides conferring modulated plant size and biomass in plants |
| 07/20/2006 | WO2006075784A1 ANTI-α9 INTEGRIN ANTIBODY AND THE USE THEREOF |
| 07/20/2006 | WO2006075671A1 Method for removing desired chromosome and tailor-made medical treatment utilizing the same |
| 07/20/2006 | WO2006075597A1 Method of culturing cells under regulation in the extension direction |
| 07/20/2006 | WO2006075187A2 Animals exhibiting an altered preference for an addictive substance |
| 07/20/2006 | WO2006074891A2 Proteins containing regulatory t-cells for the therapy and diagnosis of illnesses |
| 07/20/2006 | WO2006074547A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 07/20/2006 | WO2006074524A1 Virus recovery medium, use thereof and viral diagnostic kit including same |
| 07/20/2006 | WO2006061626A3 Complexes and methods |
| 07/20/2006 | WO2006051069A3 Defective influenza virus particles |
| 07/20/2006 | WO2006040763A8 Isolated primate embryonic cells and methods of generating and using same |
| 07/20/2006 | WO2006031926A3 Methods for the isolation and expansion of cord blood derived t regulatory cells |
| 07/20/2006 | WO2006014985A3 Genetic immunization of transgenic animals with non-eukaryotic expression systems |
| 07/20/2006 | WO2005115121A3 Adenylyl cyclase antibodies, compositions and uses thereof |
| 07/20/2006 | WO2005111217A3 Nicotiana nucleic acid molecules and uses thereof |
| 07/20/2006 | WO2005097190A3 Systems and methods for providing a stem cell bank |
| 07/20/2006 | WO2005085430A3 Adzymes and uses thereof |
| 07/20/2006 | WO2005046581A3 P18 in stem cell manipulations |
| 07/20/2006 | WO2003084467A3 Epitope constructs comprising antigen presenting cell targeting mechanisms |
| 07/20/2006 | WO2003083045A3 Lambda integrase mediated recombination in plants |
| 07/20/2006 | US20060162027 Transcriptional activators involved in abiotic stress tolerance |
| 07/20/2006 | US20060162026 Expressing TGF-beta proteins in plant plastids |
| 07/20/2006 | US20060162023 Plants having changed development and a method for making the same |
| 07/20/2006 | US20060162021 Enhanced amylose production in plants |
| 07/20/2006 | US20060162020 Promoters for the expression of genes in tagetes |
| 07/20/2006 | US20060162019 Novel plant receptor-like kinases |
| 07/20/2006 | US20060162017 Hybrid cotton plants and seeds, and methods and systems of generating same |
| 07/20/2006 | US20060162015 Inducible deoxyhypusine synthase promoter from maize |
| 07/20/2006 | US20060162013 Promoters functional in plant plastids |
| 07/20/2006 | US20060162012 Inbred maize line NP2467 |
| 07/20/2006 | US20060162011 Rice cultivar ' Banks ' |
| 07/20/2006 | US20060162010 DNA construct comprising polynucleotide having promoter activity; herbicide tolerance gene |
| 07/20/2006 | US20060162009 Amino polyol amine oxidase polynucleotides and related polypeptides and methods of use |
| 07/20/2006 | US20060162008 Enzymes and polynucleotides encoding the same |
| 07/20/2006 | US20060162006 Polynucleotides and polypeptides in plants |
| 07/20/2006 | US20060162003 protecting a mammalian embryo from embryotoxic effects by administering the prostaglandin F2 alpha receptor antagonist to a recipient female mammal; reduce transplant rejection when transfer embryo in cattle |
| 07/20/2006 | US20060162001 Mammalian grainyhead transcription factors |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060160764 LIMKs as modifiers of p53 pathway and methods of use |
| 07/20/2006 | US20060160700 Nadh-dependent cytochrome b5 reductase as target for herbicides |
| 07/20/2006 | US20060160218 Transdifferentiation of cells and tissues |
| 07/20/2006 | US20060160217 Novel nucleic acids from sesame plants |
| 07/20/2006 | US20060160216 screening a compound affecting malaria parasite development in an infected human liver; using immortalized hepatocytes in treatment of parasitic infection; liver disorders; drug screening |
| 07/20/2006 | US20060160215 Methods of developing a stem cell line |
| 07/20/2006 | US20060160214 Engineered intervertebral disc tissue |
| 07/20/2006 | US20060160213 Enhancement of mammalian embryo development |
| 07/20/2006 | US20060160212 Process for isolating haemocyanin |
| 07/20/2006 | US20060160202 Bacterial artificial chromosome vector for use in the propagation and transfer of genetic material; equine herpesvirus (EHV) |
| 07/20/2006 | US20060160182 Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production |
| 07/20/2006 | US20060160180 Control and optimization of cell culture conditions is critically important for successful commercial production of proteins and polypeptides; changing the culture from a first set of culture conditions to a second set of culture conditions so that a metabolic shift of the cells is achieved |
| 07/20/2006 | US20060160178 Methods of generating antibody diversity in vitro |
| 07/20/2006 | US20060160177 Peptide extended glycosylated polypeptides |
| 07/20/2006 | US20060160174 Modified l49-sfv exhibiting increased stability and methods of use thereof |
| 07/20/2006 | US20060160159 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 07/20/2006 | US20060160150 Solid phase synthesis; antibodies; kits |
| 07/20/2006 | US20060160146 Method of screening compound affecting amyloid beta production |
| 07/20/2006 | US20060160140 Human nuclear receptor protein nNR7-1 |
| 07/20/2006 | US20060160139 Rhesus BCRP and antibodies thereto |
| 07/20/2006 | US20060160091 Polynucleotides encoding a class II cytokine receptor |
| 07/20/2006 | US20060159722 Layered aligned polymer structures and methods of making same |
| 07/20/2006 | US20060159718 Method for the production of porous carbon-based molded bodies, and use thereof as cell culture carrier systems and culture systems |
| 07/20/2006 | US20060159703 Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159670 Pharmaceuticals containing multipotential precursor cells from tissues containing sensory receptors |
| 07/20/2006 | US20060159669 Novel uses of PPAR modulators and professional APCs manipulated by the same |
| 07/20/2006 | US20060159667 Rapamycin-resistant Th2 cells that are therapeutically effective where the Th2 cells are selected from T cells cultured in vitro in rapamycin or a rapamycin derivative and interleukin-4; improved, safer immunostimulants having long-lasting effects for the prevention oftransplant rejection; nontoxic |
| 07/20/2006 | US20060159662 Therapeutic anti-melanoma compounds |
| 07/20/2006 | US20060159623 Stem cells for use in locating and targeting tumor cells |
| 07/20/2006 | CA2598022A1 Method for removing desired chromosome and tailor-made medical treatment utilizing the same |
| 07/20/2006 | CA2594728A1 Maize cyclo1 gene and promoter |
| 07/20/2006 | CA2594572A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof |
| 07/20/2006 | CA2594412A1 Virus recovery medium, use thereof and viral diagnostic kit including same |
| 07/20/2006 | CA2594013A1 Methods and compositions related to modulating the extracellular stem cell environment |
| 07/20/2006 | CA2593777A1 Anti-.alpha.9 integrin antibody and the use thereof |
| 07/20/2006 | CA2593668A1 Bone marrow stromal cells for immunoprotection of transplanted neural stem cells |
| 07/20/2006 | CA2584812A1 Process for constructing strain having compactin hydroxylation ability |
| 07/20/2006 | CA2567047A1 Alphavirus replicon packaging constructs |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681353A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35 |